Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
450 participants
INTERVENTIONAL
2022-04-06
2023-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The evaluation of these liver disorders in psychiatric inpatients remains very little explored in France, contributing to the poor overall medical status of psychiatric patients.
The LIVERSPIN study aims to estimate the prevalence rates of liver pathologies in psychiatric inpatients and to explore the factors associated with the existence of a liver pathology
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
FIbrosis and Steatosis in Patients With Psychiatric Illness
NCT05965232
Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry
NCT01611337
Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With Schizophrenia
NCT05174533
Pain in Psychiatry : Impact on Length of Hospital Stays
NCT02822430
Influence of Environmental Factors and Schizophrenia
NCT03296384
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All hospitalized patients can potentially be recruited. They will benefit from the usual clinical and paraclinical examinations as part of their hospitalization diagnostic work-up. For the determination of biological analyses, a blood sample will be taken following inclusion as well as a Fibroscan examination.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All inpatients in Vinatier psychiatric Hospital
All hospitalized patients can potentially be recruited. They will benefit from the usual clinical and paraclinical examinations as part of their hospitalization diagnostic work-up. For the determination of biological analyses, a blood sample will be taken following inclusion as well as a Fibroscan examination.
To estimate the prevalence rates of liver disease in psychiatric inpatients and to explore factors associated with the existence of liver disease.
Patients will receive the usual clinical and paraclinical examinations as part of their hospitalization diagnostic workup. For the biological analyses, a blood sample will be taken following inclusion as well as a Fibroscan examination.
Data will be collected from the patient, or if necessary from the health care team, using the medical record (interview and/or self-questionnaires).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
To estimate the prevalence rates of liver disease in psychiatric inpatients and to explore factors associated with the existence of liver disease.
Patients will receive the usual clinical and paraclinical examinations as part of their hospitalization diagnostic workup. For the biological analyses, a blood sample will be taken following inclusion as well as a Fibroscan examination.
Data will be collected from the patient, or if necessary from the health care team, using the medical record (interview and/or self-questionnaires).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Social insurance
* Current hospitalization in any psychiatric unit of the participating center
* Adult or legal representative who has given written and informed consent to participate in the study. By default, the oral consent of the adult will be obtained (as well as the written consent of the legal representative)
* Information given to the curator(for people under curatorship)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Hôpital le Vinatier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin ROLLAND, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CH LE VINATIER
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Le Vinatier
Bron, Auvergne-Rhône-Alpes, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A02796-35
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.